Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$7.94 - $11.31 $551,814 - $786,022
-69,498 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$10.44 - $14.85 $725,559 - $1.03 Million
69,498 New
69,498 $787,000
Q1 2019

May 15, 2019

SELL
$7.14 - $9.85 $460,815 - $635,719
-64,540 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$7.26 - $13.29 $468,560 - $857,736
64,540 New
64,540 $536,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $193M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.